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Introduction
Pulmonary involvement in juvenile dermatomyositis
(JDM) is frequent and associated with poor outcome.
However, a systematic assessment of pulmonary function
and high-resolution computed tomography (HRCT) was
rarely reported in this population.
Objectives
To assess pulmonary function and HRCT in JDM patients
and to evaluate possible associations between pulmonary
abnormalities and disease activity, cumulative damage and
health-related quality of life (HRQL) scores.
Methods
A cross-sectional study was performed in 20 JDM
patients. Pulmonary function test included spirometry,
body plethysmography and diffusion capacity for carbon
monoxide (DLCO). They were also carried out six-min-
ute walk test (6MWT) and HRCT scan. Disease activity
score (DAS), childhood myositis assessment scale
(CMAS), myositis damage index (MDI) and HRQL
(Pediatric Quality of Life Inventory - PedsQL) data were
also assessed
Results
The mean age was 11.6 years (6-18). Subclinical mild/
moderate obstruction according to American Thoracic
Society criteria was observed in 35% and DLCO was
reduced in 20% of JDM patients. Spirometric and/or
DLCO abnormalities were observed in 45% of patients. In
plethysmography, reduced total lung capacity (TLC) and
conductance were observed in 25% and 50% of JDM
patients, respectively. In contrast, increased resistance and
residual volume (RV)/TLC were evidenced in 10% and
35% of JDM patients, respectively. Thirteen patients
underwent HRCT and 8 had alterations: interstitial lung
disease in 6 and a mixed pattern in two. A positive correla-
tion was observed between DAS and ratio between forced
expiratory volume in one second and vital capacity (VEF1/
CV) (r=+0.50, p=0.003), conductance (r=+0.46, p=0.045)
and HRCT score (r=+0.60, p=0.003). A positive correlation
was observed between CMAS and VEF1/CV (r=+0.47,
p=0.042), DLCO (r=+0.67, p=0,002) and 6MWT (r=+0.54,
p=0.048), and negative correlation between DAS and
HRCT score (r=-0.63, p=0.021). Correlations were identi-
fied between MDI and conductance (r=+0.72, p=0.0004),
DLCO (r=-0.46, p=0.042) and HRCT score (r=+0,81,
p=0.0008); and between PedsQL and VEF1/CV (r=+0.45,
p=0.046), conductance (r=-0.60, p=0.006) and HRCT
score (r=+0.62, p=0.024). Correlations were also observed
between HRCT score and VEF1/CV (r=-0.64, p=0.017),
forced expiratory flow between 25 and 75% of vital capa-
city (FEF25%>75 %) (r=-0.59, p=0.035) and conductance
(r=+0.78, p=0.0018).
Conclusion
Subclinical pulmonary abnormalities were frequent in
this rare idiopathic inflammatory myopathy. Importantly,
these findings may be related to disease severity and
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